117
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer

, , , ORCID Icon &
Pages 6309-6317 | Published online: 10 Aug 2021

References

  • SiegelRL, MillerKD, JemalA. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30. doi:10.3322/caac.2138728055103
  • NussbaumES, DjalilianHR, ChoKH, HallWA. Brain metastases. histology, multiplicity, surgery, and survival. Cancer. 1996;78:1781–1788. doi:10.1002/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.0.CO;2-U8859192
  • ShiY, SunY, YuJ, et al. [China experts consensus on the diagnosis and treatment of brain metastases of lung cancer (2017 version)]. Zhongguo Fei Ai Za Zhi. 2017;20:1–13. [Chinese].28103967
  • LombardiG, Di StefanoAL, FarinaP, et al. Systemic treatments for brain metastases from breast cancer, non-small cell lung cancer, melanoma and renal cell carcinoma: an overview of the literature. Cancer Treat Rev. 2014;40:951–959. doi:10.1016/j.ctrv.2014.05.00724909312
  • OwonikokoTK, ArbiserJ, ZelnakA, et al. Current approaches to the treatment of metastatic brain tumours. Nat Rev Clin Oncol. 2014;11:203–222. doi:10.1038/nrclinonc.2014.2524569448
  • MehtaMP, RodrigusP, TerhaardCH, et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole brain radiation therapy in brain metastases. J Clin Oncol. 2003;21:2529–2536. doi:10.1200/JCO.2003.12.12212829672
  • BulbulA, FordePM, MurtuzaA, et al. Systemic treatment options for brain metastases from non-small-cell lung cancer. Oncology. 2018;32:156–163.29684234
  • LimSH, LeeJY, LeeMY, et al. A randomized Phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer. Ann Oncol. 2015;26(4):762–768. doi:10.1093/annonc/mdu58425538174
  • UchinoM, NagaoT, SeikiY, et al. Radiosurgery for cystic metastatic brain tumor. No Shinkei Geka. 2000;28:417–421.10806624
  • GardnerWJ, CollisJS, LewisLA. Cystic brain tumors and the blood-brain barrier. Comparison of protein fractions in cyst fluids and sera. Arch Neurol. 1963;8:291–298. doi:10.1001/archneur.1963.0046003007500713946556
  • SunB, HuangZ, WuS, et al. Cystic brain metastasis is associated with poor prognosis in patients with advanced breast cancer. Oncotarget. 2016;7:74006–74014. doi:10.18632/oncotarget.1217627659537
  • SekineA, KatoT, HagiwaraE, et al. Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: distinguishing influence of exon 19 deletion on radiographic features. Lung Cancer. 2012;77:64–69. doi:10.1016/j.lungcan.2011.12.01722335887
  • ShinDY, NaII, KimCH, et al. EGFR mutation and brain metastasis in pulmonary adenocarcinomas. J Thorac Oncol. 2014;9:195–199. doi:10.1097/JTO.000000000000006924419416
  • RusthovenCG, DoebeleRC. Management of brain metastases in ALK-positive non-small-cell lung cancer. J Clin Oncol. 2016;34:2814–2819. doi:10.1200/JCO.2016.67.241027298405
  • GrubbWR, MachtayM, DowlatiA, BiswasT. Diffuse atypical cystic brain metastases in ALK+ NSCLC treated with whole brain radiation and second-generation ALK-targeted therapy. Pract Radiat Oncol. 2019;9:e129–e133. doi:10.1016/j.prro.2018.11.00230665865
  • MartaGN, da Cunha Colombo BonadioRR, MartinsRE, et al. Cystic brain metastases in ALK-rearranged non-small cell lung cancer. Ecancermedicalscience. 2018;12:818.
  • KimSH, HyunJW, KimHJ, et al. De novo cystic brain lesions mimicking neurocysticercosis in ALK-positive lung cancer. Lung Cancer. 2017;110:53–55. doi:10.1016/j.lungcan.2017.06.00328676219
  • SaraceniC, LiPM, GainorJF, et al. Cystic brain metastases in NSCLC harboring the EML4-ALK translocation after treatment with crizotinib. J Thorac Oncol. 2015;10:1116–1117. doi:10.1097/JTO.000000000000040926134230
  • NarayananV, HonceMJ, MehrotraS, CamidgeDR. Cystic brain metastases occurring in anaplastic lymphoma kinase gene rearranged non-small-cell lung cancer patients receiving crizotinib. Clin Lung Cancer. 2016;17:85–90. doi:10.1016/j.cllc.2015.07.00326314227
  • HayashiH, OkamotoI, TanizakiJ, et al. Cystic brain metastasis in non-small-cell lung cancer with ALK rearrangement. J Clin Oncol. 2014;32:e122–e124. doi:10.1200/JCO.2012.48.214124567432
  • ZeeYK, ChinTM, WongAS. Fatal cystic change of brain metastasis after response to gefitinib in non-small-cell lung cancer. J Clin Oncol. 2009;27:e145–146. doi:10.1200/JCO.2009.22.450119667265
  • BrigellRH, CagneyDN, MartinAM, et al. Local control after brain-directed radiation in patients with cystic versus solid brain metastases. J Neurooncol. 2019;142(2):355–363. doi:10.1007/s11060-019-03106-130715665
  • WangH, LiuX, JiangX, et al. Cystic brain metastases had slower speed of tumor shrinkage but similar prognosis compared with solid tumors that underwent radiosurgery treatment. Cancer Manag Res. 2019;11:1753–1763. doi:10.2147/CMAR.S18867430858728